Advantages of point-of-care diagnostics:

1. Patients are observed in essential consideration offices by a doctor staff that is accountable for endorsing medications and following reactions. They are generally self performed,regardless of the way that they are often times managed by clinical professionals, leaving patients considerably more liable for treating their own sickness⁷.

2. In-home POC testing reduces the amount of hospital visits, travel expenses, and work hours⁸.

3. Individuals who are granted the right to do their own tests are most likely to continue with counseling (adherence to diagnosis and treatment regimens)⁹.

4. The cost boundaries of point-of-care diagnostics shift from the use of conventional research center investigation. Perusers (instruments) aremore modest and further developed than research facility gadgets, so they are more affordable yet just perform on a couple of analyses¹⁰.

5. Point-of-care studies have the ability to lower hospital costs in an indirect and sometimes drastic way. Rapid POC out comes can prevent hospitalizations.¹¹

Devices used for POCD:

1. Biosensor:

Chemical sensing is a real-time way of collecting precise information about a chemical's structure. The key component of a typical sensor is a chemically sensitive layer that is coupled to a transducer that converts the (bio) chemical transformation into a signal, which is then usually transformed into a digital electronic result. Biosensors are logical instruments used to investigate biomaterial tests to accomplish a superior comprehension of their profile creation, design, and capacity by making an interpretation of a natural response into an electrical sign. The term 'biosensor' is regularly used to allude to sensor frame works that are utilized to evaluate the convergence of substances and different boundaries of natural importance, despite the fact that they don't really incorporate an organic frame work. Most of biosensors can be partitioned into four classes dependent on four separate rules which is bio fondness, reactant, transmembrane, and cell sensors¹². Scientific gadgets comprise of an organic acknowledgment component straight forwardly interfaced to assign transducer, which together contribute the convergence of an analyte (or set of related analytes) to a perceptible response. Biosensors are a rapidly growing field, with an estimated annual growth rate of 60%, with the majority of demand coming from the healthcare sector, though demand fromother sectors such as food safety evaluation andsurrounding management is alsoincreasing¹³.

Fig. 2: A typical biosensor components

Biosensordetection process:

A Catalyst, a counter acting agent and a nucleic corrosive is liked as the natural materials for conventional strategies like Physical or film measurement and non-covalent or covalent restricting. The transducer changes the organic response over toan electrical sign after the bio component collaborates with the analyte which is beingestimated. Biosensor contains a natural segment that proceeds as the sensor just as an electronic segment that recognizes and communicates the sign. The analyte ties to the natural substance, bringing about the electronic response that can be dissected. Infrequently the analyte is changed into a substance that is correlated with the arrival of warmth, oxygen, electrons, or hydrogen particles. The item connected alterations are then changed over into electrical signs by the transducer, which can be intensified and dissected. The sensor is alluded to a sa fondness sensor if the bio component ties to the analyte, the sensor is alluded to as metabolic sensor if the bio component and analyte causes a compound progress which is utilized to decide the centralization of a substrate and the sensor is alluded to as a synergist sensor if the organic part interfaces with the analyte however doesn't change it artificially yet it changes it to a helper substrate.The most significant feature of a biosensor is the transducer, which uses a physical transition connected with the reaction¹⁴. This may be heat produced by the reaction (calorimetric biosensors), changes in charge distribution producing an electrical potential (potentio metric biosensors), electron movement produced in a redox reaction(amperometric biosensors), light produced during the reaction or a difference in lightabsorbance between the reactants and products (optical biosensors), or effects caused by the reagent(piezo-electric biosensors)¹⁵. There are various types of biosensors-

Fig: 3 Types of biosensors

1. Resonant Biosensors:

Resonant biosensors are biosensors in which an acoustic wave transducer is attached to a bio-element antibody. If the analyte molecule binds toward the membrane, its weight changes. The resulting mass differential raises the transducer's resonant frequency. This recurrence difference is then determined¹⁷.

2. Optical-detection biosensors:

For this sort of biosensor, the yield transduced signal which is dissected is light. Optical diffraction or electro chemiluminescence might be utilized to construct this sort ofbiosensor.¹⁸.

3. Thermal-detectionbiosensor:

This sort of biosensor exploits perhaps the most fundamental properties of naturalresponses: heat assimilation or handling, which swaps the temperature of the mediumwherein the response, happens. They're made by intertwining immobilized catalystatoms with temperature sensors. Temperature is generallyestimated by a thermistor, and analoguesgadgets are known as protein thermistors¹⁹.

4. Ion sensitive biosensor:

These sorts of biosensors are semiconductor FET’s which have a particle touch surface. As particles and semiconductors communicate, the surface electrical potential fluctuates and the variety can be estimated²⁰.

5. Electro chemical biosensors:

This kind of bio sensor is used to identify hybridized DNA, DNA binding drugs, glucose concentration, and other parameters. The basic theory behind this class of biosensors is that a chemical reaction produces or absorbs ions or electrons, resulting in a change in the electrical properties of the solution that can be used as a measuring parameter. These biosensors are classified into three groups based on the electrical parameters they are-

I. Conductimetric

The electrical conductance or resistance of the solution is the measured parameter in this type of biosensor. If the electrochemical reaction releasesions or electrons, the overall conductivity or resistivity of the solution changes. Afterthat, the deviation is measured and tuned to the required size²¹.

II. Amperometric

The calculated parameter in this type of biosensor is current,and it is a high sensitivity biosensor capable of detecting electro active species in biological research samples. Since biological research samples cannot be electro active by itself, enzymes are used to catalyze the processing of radio-active species.

III. Potentiometric

The calculated parameter is the oxidation or reduction potential of an electrochemical reaction. The principles of operation of these biosensors are based on the fact that when a ramp voltage is applied to an electrode in solution, electro chemical reactions occur, resulting in current flow, and the voltage at which these reactions occur effects aparticularreactionandaspecificspecies²².

Application of biosensors:

As we know biosensors have a wide variety of application in various fields like biological, industrial and military. It is used in²³-

Fig. 4: Applications of biosensor

2. Nanosensors:

Humans living in the new industrial and knowledge world need health care facilitiesthat are fast, reliable, and low-cost. Daily health screening, illness diagnostics, and therapeutics now necessitate intelligent biomedical devices capable of probing body disorders in a non-intrusive or marginally intrusive manner and generating facts andstudy. These devices can be small, low-risk, and convenient enough that can be used at point-of-care or in home settings at a minimal price without the intervention of specialized medical personnel. Today, there is an increasing debate about the prevention of certain health problems that are generally caused by living standards and lifestyle circumstances, such as food supplies and water safety, individuals and public well being, degradation of environment and opioid misuse. It will be ideal to have smart devices that would track the freshness and spoilage of food items in real time, control air quality, and warn of impending health risks.²⁴

Methods of manufacturing of point – of -carediagnostics for glucose kit using nano materials Rawmaterials:

Polyamide, polyolefin, polysulfone, or cellulose is used to make the test strips. There's also a silica and powdered titanium dioxide hydroxyl elastomer that's water-based. The printedcircuit board and nanosensors are housed in a plastic case that makes up the metre. The measurements of the blood glucose will be shown on a liquid crystal monitor (LCD).A rubber lancet contains a stainless-steel needle³⁵.

Design:

Glucose test kits come in many different varieties. Needles are also installed in some gluco meters. When the user clicks the release button, the needle prick is ejected and a sample is withdrawn. Others will like a lancet and test strips that are not included with the kit. Glucose kit sin this form are the most used³⁶. At the top of the metre, there is usually an LCD display. A horse shoe-shaped slot runs from the middle to the right, where the test strip should be inserted. A sensor is located under this slot and transmits the blood sample spread out. The gadget is battery-powered and normally has a short-term memory for remembering previous glucose measurements. Some instruments may be linked to computer programmes that log readings and print out maps and graphs that’s how major improvements³⁷.

Manufacturing process:

Test strips:

A porous membrane consisting of polyester, polyamide, polyolefin, polysulfone, or cellulose is suitable for the test strip. A test strip is made by combining 40.0g of an anionically stabilized water-based hydroxyl elastomer (3.80 parts by weight sodium lauryl sulphate and 0.80 parts byweightdo decyl benzene sulfonic acid with around 5% by weight colloidal silica and 5.0g of finely ground titanium dioxide. After that, the batch is combined with 1.0g of tetra methyl benzidine, 5,000 unit shores radish peroxidase, 5,000units glucoseoxidase, 0.12 gtris, and 10g of water (hydroxyl methyl) amino methane (buffer)³⁸. To ensure a homogeneous mixture, the batch is placed onto a polyethylene tere phthalate sheet for added structural stability in a carrier matrix and dried at 122°F (50°C) for 20 minutes after mixing. In a 50ml container, dry add 100.0mg of 3-dimethyl amino benzoic acid, 13.0mg of 3-methyl-2-benzo thiazolinone hydrazone,100.0mg of citric acid monohydrate-sodium citrate di hydrate, and 50.0mg of Loval. These dry materials are combined thoroughly with a spatula, then 1.5g of carboxy methylcellulose 10 percent water solution is added and thoroughly mixed with the above solids. Then, add 2.1g of dialyzed carboxylated vinyl acetate ethyl co polymer latex and fully blend I tin.The batch is cast onto a polyethylene terephthalate layer for additional structuralstability in a carrier matrix and dried at 122°F (50°C) for 20 minutes after mixing to ensure a homogeneous blend³⁹.

By putting about 100g of carboxylated vinyl acetate/ethylene copolymer emulsion into membrane tubing, the latex copolymer was dialyzed (the isolation of larger particlesfrom smaller particles). Low molecular weight ions, untreated monomer, catalyst,surfactant, and other substances were allowed to move through the membrane bysoaking it in a water (distilled) bath at 68°F (20°C) for 60 hours. Using an overflow method, the water was adjusted every 60minutes for 60 hours. The tubing is then filled with 0.18ml of glucose oxidase as a vapour. Following that,peroxidase is piped as a solvent into the tube, followed by tartrazine. The resultant combination is carefully combined. Enable fora15-minute rest period after mixing this mixture.Prior to being coated with theforementioned formula, a polished-matte vinyl supportwas sliced into cell rows and rubbed clean with methanol. The mixture is drawn into aten-milliliter syringe, and approximately ten six-millimeter drops are mounted on each cell row. The coated cell row is heated in an oven for 30 minutes at 98.6°F(37°C),then for two hours at 113°F (45°C). For each cell, the coating and spreading of the mixture is replicated. The cell rows were then cut into strips of the desired size. These strips were packaged with absorbent packs of silica gel and dried overnight atapproximately 86°F(30°C) and 25mm/Hg vacuum.The glucometer- in a receiving chamber, a pellet of enclosing material (thermoplastic resins used inadditive manufacturing, such as phenol resin, epoxy resin, silicone resin, unsaturated polyester resin,and other thermosetting resins) is placed, and a moulding press is loaded into the mould cavity⁴⁰. A prick of the patient's finger is used to apply a sample to the test strip. After that, thetest strip is placed into the glucometer. The blood glucose reading occurs after a briefpause of around 10-15seconds.The blood glucose reading occurs after a brief pause of around 10-15 seconds. The integrated circuits (of the glucose detector)are encapsulated by heating andpressing the encapsulating material pellet inside the chamber with a transfer plunger,which allows the pellet to liquefy and flow into the mould cavities through narrow passages between the chamber and the mould cavities. The moulding press is opened and the mould pieces are removed after the encapsulating film has solidified again⁴¹.

CONCLUSION:

Pharmaceutical nanotechnology has the potential toenhance materials and medical equipment while also assisting in the development ofnew drugs. Nanotechnology gives the pharmaceutical industry a new lease on life byintroducing cutting-edge patentable innovations in response to sales losses incurred by off-patent medicines. This technology has the ability to help with disease identification, diagnosis, treatment, and prevention. Pharmaceutical nanotechnology could have a significant impact on disease preventionefforts. For global health, there is a pressing need for reliable diagnostic methods. Existing approaches are insufficient to satisfy the demand, because they are unavailable to clinicians in developed countries or because they are too expensive. The creation of nanosensors for these diagnostics is a critical subject of study in order to provide best quality patient care and to control Health of the patients. The susceptibility and linear ranges of anumber of diseases have been increased thanks to nanotechnology, which is necessaryin point-of-care diagnostics. Although there has been advancement in this field, and many scientists have devoted their resources to developing novel nano sensors for point-of-care diagnosis of various diseases, the ultimate goal of long-term, accurate, and continuous monitoring of patients has yet to be realized. In the coming decades, a major challenge for biomedical engineers will be to transform recent research in these fields into accessible innovations that can be used on the outskirts of the health-care system. In order to create a diagnostic test that can be used in low-resource settings and has a cost-effective impact on healthcare, technology developers must communicate with clinical needs and end users in low-resource settings early in the product development process. If preventative and treatment-related causes, such asdrug delivery reliability, are not treated together, the effect of POC testing would benullified. Finally, both government and foreign organizations would continue to put more money into driving research and bringing emerging innovations to market. There are also few perplexing unanswered problems that prevent the application fromreaching its full potential. The scientist must address some troubling concerns such as protection, pollution risks, bio ethical issues, physiological, and medicinal challenges.

CONFLICT OF INTEREST:

Authors declare no conflict of interest.

REFERENCES:

1. Ahmed, W., Elhissi, A. & Subramani, K. Introduction to nano technology.Nano biomaterials Clin. Dent. 3–16 (2012) doi:10.1016/B978-1-4557-3127-5.00001-5, doi:10.21832/9781847692580-003.

2. Harper, G. N introduction. Creat. Writ. ix–xx2018)doi:10.21832/9781847692580-002.

3. Source:-https://www.wichlab.com/nanometer-scale-comparison-nanoparticle-size-comparison-nanotechnology-chart-ruler-2/

4. John H T Luong, Biosensor technology: technology push versus market pull Biotechnology Advances, 26; 2008:492-500.

5. Cass, A. E., Ferrocene-mediated enzyme electrode for amperometric determination of glucose, Analytical Chemistry 56(4); 1984: 667-671.

6. Turner, A. P., and Pickup, J. C. Diabetes mellitus: biosensors for research and management Biosensors 1(1); 1985: 85-115.

7. Turner, A. P. The Importance of the Troponin Biomarker in Myocardial Infarction Elsevier 42(8); 2013: 3184-96.

8. Lowe, C. R. An introduction to the concepts and technology of biosensors 1(1); 1985: 3-16.

9. Jose I et al, Encyclopedia of Agricultural, Food, and Biological Engineering, 2003, pp 119-123.

10. Wang, J. Electrochemical glucose biosensors Chemical reviews, 2008; 108(2): 814-825.

11. Newman, J. D., and Turner, A. P. Home Blood Glucose Biosensors: A Commercial Perspective. Biosensors and bioelectronics 20(12); 2005: 2435-2453.

12. Wang, J. Glucose biosensors: 40 years of advances and challenges Electroanalysis, 13(12); 2001: 983.

13. J. H. et al, Biosensor technology: technology push versus market pull, Biotechnology Advances 26(5); 2008: 492-500.

14. P etal. Implanted Sensors. Springer 2013; 159–190.

15. Mongra, A. J. Biomedical engineering of dental implant infections. Acad. Indus. Res. 1(6); 2012: 310-312.

16. D Orazio, Trends Biotechnol, 21(11);2003: 498-503.

17. Rich and Myszka, Grading the commercial optical biosensor literature—Class of 2008:'The Mighty Binders'JMolRecognit, 23(1); 2010: 1-64.

18. DiagnoSwiss chips: Biosensors for ultra-fast ELISA. Available from URL:http://www.diagnoswiss.com/principle_technology.html

19. Company Overview of GeneOhm Sciences, Inc. Available from URL:http://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=3037208

20. Motorola Life Sciences selects Insightful analytic technology to manufacture reliable high-quality biochips for genomics and expression data mining. Available from URL: http://www.solutionmetrics.com.au/customers/motorola.pdf

21. Rawson, D. M., Willmer, A. J., and Turner, A. P. Whole-cell biosensors for environmental monitoring. Biosensors 4(5); 1989: 299-311.

22. Terry, L., and Bordonaba, J. G. Encyclopedia of Biotechnology in Agriculture and Food.

23. Turner, Anthony, Isao Karube, and George S. Wilson. Biosensors: fundamentals and applications, Oxford University Press 1987; pp 600-630.

24. Biosensors Market by Application 2015. Retrieved from http://www.marketsandmarkets.com/: http://www.marketsandmarkets.com/Market-Reports/biosensors-market-798.html

25. Scheller, F. W., Schubert, F., Renneberg, R., Müller, H. G., Jänchen, M., and Weise, H. Biosensors: Trends and Commercialization. Biosensors 1(2); 1985: 135-160.

26. Yoo, E. H., and Lee, S. Y. Glucose biosensors: an overview of use in clinical practice Sensors, 10(5); 2010: 4558-4576.

27. Wang, J. Amperometric biosensors for clinical and therapeutic drug monitoring: a review Journal of pharmaceutical and biomedical analysis, 19(1); 1999:47-53.

28. J. I. et al Biosensors. Encyclopedia of Agricultural, Food, and Biological Engineering 2003; pp. 119-123.

29. Palleschi, G., Moscone, D., Micheli, L., and Tothill, I. E. Rapid and on-line instrumentation for food quality assurance, Woodhead publishing limited, Cambridge, UK, 2003; pp. 116-135.

30. Griffiths and Hall, Biosensors—what real progress is being made? Trends Biotechnol, 11(4); 1993: 122-30

31. Hulla,J.E.,Sahu,S.C.&Hayes,A.W.Nanotechnology:Historyandfuture.Hum.Exp.Toxicol.34,1318–1321(2015).

32. Nazarenko, Y., Zhen, H., Han, T., Lioy, P. J. &Mainelis, G. Potential forinhalation exposure to engineered nanoparticles from nanotechnology-basedcosmeticpowders. Environ.Health Perspect.120, 885–892(2013).

33. Yager, P., Domingo, G. J. &Gerdes, J. Point-of-care diagnostics for globalhealth.Annu.Rev.Biomed.Eng.10, 107–144(2018).

34. Vashist,S.K.Point-of-carediagnostics:Recentadvancesandtrends.Biosensors7,10–13(2017).

35. Gubala, V., Harris, L. F., Ricco, A. J., Tan, M. X. & Williams, D. E. Point of carediagnostics:Status andfuture.Anal.Chem.84,487–515(2012).

36. Lyberopoulou, A., Efstathopoulos, E. P. &Gazouli, M. Nanotechnology‐BasedRapid Diagnostic Tests. Proof Concepts Rapid Diagnostic Tests Technol. (2016)doi:10.5772/63908.

37. Choi, S., Tripathi, A. & Singh, D. Smart nanomaterials for biomedics. J. Biomed.Nanotechnol.10,3162–3188(2014).

38. Canyon Hydro et al. We are IntechOpen , the world ’ s leading publisher ofOpen Access books Built by scientists , for scientists TOP 1 %. Intech32, 137–144(2013).

39. Mousavi, S. M., Hashemi, S. A., Zarei, M., Amani, A. M. &Babapoor, A.Nanosensors for Chemical and Biological and Medical Applications. Med.Chem.(Los.Angeles).08, 205–217(2018).

40. Datta, S. Future Healthcare: Bioinformatics, Nano-Sensors, and EmergingInnovations.Nanosensors Theory Appl.Ind.Healthc.Def.343(2011).

41. Singh, P. & Yadava, R. D. S. Nanosensors for health care. NanosensorsforSmartCities(INC, 2020).doi:10.1016/b978-0-12-819870-4.00025-6.

42. Sheikhpour, M., Barani, L. &Kasaeian, A. Biomimetics in drug deliverysystems:A criticalreview.J.Control.Release253,97–109(2017).

43. Vincent, J. F. V., Bogatyreva, O. A., Bogatyrev, N. R., Bowyer, A. &Pahl, A. K.Biomimetics:Itspracticeandtheory.J.R.Soc.Interface3,471–482(2006).

44. Akbari jonous, Z., Shayeh, J. S., Yazdian, F., Yadegari, A., Hashemi, M., and Omidi, M. (2019). An electrochemical biosensor for prostate cancer biomarker detection using graphene oxide–gold nanostructures. Eng. Life Sci. 19, 206–216.

Received on 31.12.2021 Modified on 17.10.2022

Research J. Pharm. and Tech 2023; 16(7):3483-3488.

DOI: 10.52711/0974-360X.2023.00575